Peptide vaccines for hepatocellular carcinoma

Daisuke Nobuoka; Toshiaki Yoshikawa; Yu Sawada; Toshiyoshi Fujiwara; Tetsuya Nakatsura

doi:10.4161/hv.22473

Peptide vaccines for hepatocellular carcinoma

Daisuke Nobuoka, Toshiaki Yoshikawa, Yu Sawada, Toshiyoshi Fujiwara, Tetsuya Nakatsura

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	210-212
Number of pages	3
Journal	Human Vaccines and Immunotherapeutics
Volume	9
Issue number	1
DOIs	https://doi.org/10.4161/hv.22473
Publication status	Published - Jan 2013

Keywords

Clinical trial
Cytotoxic T lymphocyte
Glypican-3
Hepatocellular carcinoma
Peptide vaccine

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Pharmacology

Access to Document

10.4161/hv.22473

Cite this

@article{e7ba96ed4ed9434988ad745e65f2b7e6,

title = "Peptide vaccines for hepatocellular carcinoma",

keywords = "Clinical trial, Cytotoxic T lymphocyte, Glypican-3, Hepatocellular carcinoma, Peptide vaccine",

author = "Daisuke Nobuoka and Toshiaki Yoshikawa and Yu Sawada and Toshiyoshi Fujiwara and Tetsuya Nakatsura",

year = "2013",

month = jan,

doi = "10.4161/hv.22473",

language = "English",

volume = "9",

pages = "210--212",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Landes Bioscience",

number = "1",

}

TY - JOUR

T1 - Peptide vaccines for hepatocellular carcinoma

AU - Nobuoka, Daisuke

AU - Yoshikawa, Toshiaki

AU - Sawada, Yu

AU - Fujiwara, Toshiyoshi

AU - Nakatsura, Tetsuya

PY - 2013/1

Y1 - 2013/1

KW - Clinical trial

KW - Cytotoxic T lymphocyte

KW - Glypican-3

KW - Hepatocellular carcinoma

KW - Peptide vaccine

UR - http://www.scopus.com/inward/record.url?scp=84874735060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874735060&partnerID=8YFLogxK

U2 - 10.4161/hv.22473

DO - 10.4161/hv.22473

M3 - Comment/debate

C2 - 23442593

AN - SCOPUS:84874735060

VL - 9

SP - 210

EP - 212

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 1

ER -